Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (9012)	9/21/2000 5:18:14 PM
From: Galirayo	Read Replies (1) \| Respond to of 9262

INTC if you ever wanted any .. it's 49 ish. You may see em sell off most others to get INTC here. Just IMHO.

To: scaram(o)uche who wrote (9012)	9/22/2000 5:29:56 PM
From: scaram(o)uche	Respond to of 9262

Message 14428463 $BTK and $IXBT up 5.6 and 5.2%, respectively. Year 2000 active trading among the under (1) valued, (2) appreciated and (3) "stood" of lower tier biotechs has been incredible. In March, we had the same discrepancy between market caps among companies that should roughly be grouped. However, the influx of money and interest has continued, during a time where (1) there was a sharp sector correction, and (2) some of the weaker business plans came back hard. These are very good things. It all adds up to more money, looking for fewer undervalued projects. It is stock-pickers heaven. Some lower-tier biotech specialists are having huge years. Lots of private companies are being rushed to make a public debut. The magnitude of the bucks flowing in continues to amaze (see BVF thread, if you're interested in watching it). At some point, share supply is going to meet demand. That gets ugly. IMO, that's not the sort of sector correction that we saw in March. Doesn't feel, to me, like we're near that now. In any event, we're entering "biotech season" with an old truism -- find good science, early -- looking like a sound strategy to "moderate anxiety about downside potential". That's ninety percent of what it takes to be a biotech trader..... take the heebie jeebies out of it by doing lotsa homework. Position trading (frequent) has been a good strategy relative to daytrading, IMO. Good weekend, all! Rick